Thank you, Madam Chair.
My question relates to your phased-in approach. You mentioned that you'd give stakeholders some time to become compliant with any new requirements under the act and the subsequent program and regulatory framework. Obviously we're in very tough economic times right now, and I think it's important that we allow laboratories to have flexibility and that we really aim to minimize the costs.
You talked about your phases one, two, and three. I wonder if you could go into some more details about how you are planning to implement this legislation, and especially with regard to minimizing the burden on laboratories.